Holen Sie sich die Stockscreener-App
8.515
2.36%
-0.185
Schlusskurs vom Vortag:
$8.70
Offen:
$8.78
24-Stunden-Volumen:
176.98K
Relative Volume:
0.39
Marktkapitalisierung:
$1.25B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-39.54%
1M Leistung:
-41.93%
6M Leistung:
-43.93%
1J Leistung:
-48.95%
1-Tages-Spanne:
$8.47
$8.91
1-Wochen-Bereich:
$8.28
$9.95
52-Wochen-Spanne:
$8.28
$17.34
Ardent Health Inc Stock (ARDT) Company Profile
Firmenname
Ardent Health Inc
Sektor
Branche
Telefon
(615) 296-3000
Adresse
340 SEVEN SPRINGS WAY, BRENTWOOD
Vergleichen Sie ARDT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARDT
Ardent Health Inc
|
8.50 | 1.25B | 0 | 0 | 0 | 0.00 |
|
HCA
Hca Healthcare Inc
|
478.38 | 109.11B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
193.81 | 16.96B | 20.69B | 2.40B | 1.55B | 15.62 |
|
CHE
Chemed Corp
|
431.04 | 6.14B | 2.49B | 308.74M | 315.04M | 20.53 |
|
DVA
Davita Inc
|
114.62 | 8.23B | 12.82B | 936.34M | 1.47B | 10.74 |
|
UHS
Universal Health Services Inc
|
228.14 | 14.30B | 16.08B | 1.20B | 1.06B | 17.82 |
Ardent Health Inc Stock (ARDT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-10-14 | Eingeleitet | Goldman | Neutral |
| 2025-09-10 | Eingeleitet | UBS | Buy |
| 2025-07-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-08-12 | Eingeleitet | BofA Securities | Buy |
| 2024-08-12 | Eingeleitet | Citigroup | Buy |
| 2024-08-12 | Eingeleitet | JP Morgan | Neutral |
| 2024-08-12 | Eingeleitet | Leerink Partners | Outperform |
| 2024-08-12 | Eingeleitet | Loop Capital | Buy |
| 2024-08-12 | Eingeleitet | Mizuho | Outperform |
| 2024-08-12 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-08-12 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-08-12 | Eingeleitet | Stephens | Overweight |
| 2024-08-12 | Eingeleitet | Truist | Buy |
Alle ansehen
Ardent Health Inc Aktie (ARDT) Neueste Nachrichten
Is Ardent Health Inc. stock a contrarian opportunityJuly 2025 Retail & Free AI Powered Buy and Sell Recommendations - newser.com
Can Ardent Health Partners Inc. stock outperform in 2025 bull marketTrade Analysis Summary & Scalable Portfolio Growth Ideas - newser.com
Is Ardent Health Partners Inc. stock a buy in volatile markets2025 Support & Resistance & Low Risk Entry Point Guides - newser.com
What makes Ardent Health Inc. stock appealing to growth investorsQuarterly Profit Report & Free Weekly Watchlist of Top Performers - newser.com
Is Ardent Health Inc. stock positioned for secular growthAnalyst Upgrade & Smart Allocation Stock Tips - newser.com
How dovish Fed policy supports Ardent Health Inc. stock2025 Major Catalysts & Breakout Confirmation Trade Signals - newser.com
Can Ardent Health Inc. stock withstand sector downturns2025 Buyback Activity & Fast Gain Swing Alerts - newser.com
What technical charts say about Ardent Health Partners Inc. stockWeekly Stock Summary & Short-Term Trading Opportunity Alerts - newser.com
Can Ardent Health Inc. stock stage a strong rebound this quarterEarnings Recap Summary & High Conviction Buy Zone Picks - newser.com
Why Ardent Health Inc. stock stays undervaluedMarket Movers & Growth Focused Stock Pick Reports - newser.com
When is the best time to exit Ardent Health Partners Inc.2025 Market WrapUp & Long-Term Capital Growth Strategies - newser.com
Ardent Health Announces Enterprise Rollout of Ambience Healthcare's AI Platform for Documentation, Coding and Clinical Workflows - thespectrum.com
ARDT Investors Have Opportunity to Join Ardent Health, Inc. Fraud Investigation with the Schall Law Firm - The AI Journal
Ardent Health (ARDT) Faces Investor Scrutiny Amid Problems - GlobeNewswire
ARDENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardent Health, Inc. on Behalf of ... - Bluefield Daily Telegraph
ARDENT ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Ardent Health Announces $50M Stock Repurchase Program - TipRanks
Ardent Health, Inc. Announces $50 Million Share Repurchase Program - TradingView
Is Ardent Health Partners Inc. stock gaining market shareQuarterly Growth Report & Stepwise Trade Signal Guides - newser.com
Ardent Health, Inc. authorizes a Buyback Plan. - MarketScreener
Ardent Health, Inc. announces an Equity Buyback for $50 million worth of its shares. - MarketScreener
ARDT: Mizuho Lowers Price Target for Ardent Health | ARDT Stock News - GuruFocus
Amer Sports Posts Upbeat Q3 Earnings, Joins Diginex, James Hardie Industries And Other Big Stocks Moving Higher On Tuesday - Benzinga
Ardent Health announces $50M share repurchase authorization - MSN
Guggenheim lowers Ardent Health Partners stock price target on margin pressure - Investing.com Australia
Ardent Health announces $50 million share repurchase program authorization - MarketScreener
Ardent Health Announces $50 Million Share Repurchase Program Authorization - MarketScreener
Target Corporation (NYSE: TGT) Warns Investors on TRC Capital $89 Mini-Tender Offer - Stock Titan
Ardent Health price target lowered to $13 from $20 at Mizuho - TipRanks
Ardent Health price target lowered to $15 from $18 at Guggenheim - TipRanks
Ardent Health price target lowered to $14.50 from $17 at UBS - TipRanks
UBS Adjusts Price Target on Ardent Health Partners to $14.50 From $17, Maintains Buy Rating - MarketScreener
Has Ardent Health Partners Inc. found a price floor2025 Trading Volume Trends & Accurate Entry/Exit Alerts - newser.com
This Dell Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday - Benzinga
Finanzdaten der Ardent Health Inc-Aktie (ARDT)
Es liegen keine Finanzdaten für Ardent Health Inc (ARDT) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
2.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):